Raymond James & Associates’s JPMorgan U.S. Dividend ETF JDIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-41,196
Closed -$1.3M 4196
2022
Q2
$1.3M Sell
41,196
-1,563
-4% -$52.9K ﹤0.01% 2279
2022
Q1
$1.5M Buy
42,759
+21,166
+98% +$718K ﹤0.01% 2332
2021
Q4
$738K Buy
21,593
+3,047
+16% +$101K ﹤0.01% 2820
2021
Q3
$588K Buy
18,546
+1,963
+12% +$64K ﹤0.01% 2947
2021
Q2
$540K Buy
16,583
+9,839
+146% +$320K ﹤0.01% 3025
2021
Q1
$209K Buy
+6,744
New +$196K ﹤0.01% 3578

Raymond James & Associates's JDIV Position: Q3 2022 in Review

Raymond James & Associates sold out of JPMorgan U.S. Dividend ETF (JDIV) in Q3 2022, closing a stake of 41,196 shares — an estimated $1.3M sold.

Raymond James & Associates first reported a position in JDIV in Q1 2021 and held it in 6 quarters. The position peaked at $1.5M in Q1 2022. 0 funds tracked by Wall St. Rank hold JDIV as of Q3 2022.

  • Raymond James & Associates reported no remaining JPMorgan U.S. Dividend ETF position as of Q3 2022 after selling out during the quarter.
  • Raymond James & Associates sold 41,196 JPMorgan U.S. Dividend ETF shares in Q3 2022, an estimated $1.3M.
  • Raymond James & Associates first reported a position in JPMorgan U.S. Dividend ETF in Q1 2021 and held it in 6 quarters.
  • Raymond James & Associates's JPMorgan U.S. Dividend ETF position peaked at $1.5M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held JPMorgan U.S. Dividend ETF as of Q3 2022.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.